MedPath

A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT

Phase 2
Completed
Conditions
HIV Infections
Registration Number
NCT00000653
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Brief Summary

To evaluate and compare the long-term (48-177 weeks) safety, tolerance, and efficacy of two doses of zalcitabine ( dideoxycytidine; ddC ) taken orally every 8 hours in children with symptomatic HIV infection who have one of the following: intolerance to zidovudine ( AZT ) (development of toxicity during prolonged AZT therapy), demonstrated disease progression after 6 months of AZT therapy, OR both AZT intolerance and disease progression after 6 months of AZT therapy.

As useful as AZT appears to be in the treatment of patients infected with HIV, it is associated with significant toxicity in some patients, and it does not prevent ultimate progression to AIDS and eventual mortality. Thus, there is a clear need for new antiretroviral drugs, and ddC is one such promising agent.

Detailed Description

As useful as AZT appears to be in the treatment of patients infected with HIV, it is associated with significant toxicity in some patients, and it does not prevent ultimate progression to AIDS and eventual mortality. Thus, there is a clear need for new antiretroviral drugs, and ddC is one such promising agent.

Patients receive oral ddC for 48 to 177 weeks.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
140
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (35)

St. Christopher's Hosp. for Children

πŸ‡ΊπŸ‡Έ

Philadelphia, Pennsylvania, United States

Chicago Children's CRS

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

Johns Hopkins Hosp. & Health System - Dept. of Peds., Div. of Infectious Diseases

πŸ‡ΊπŸ‡Έ

Baltimore, Maryland, United States

UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS

πŸ‡ΊπŸ‡Έ

Los Angeles, California, United States

Emory Univ. School of Medicine, Dept. of Peds., Div. of Infectious Diseases

πŸ‡ΊπŸ‡Έ

Atlanta, Georgia, United States

Univ. of Maryland Med. Ctr., Div. of Ped. Immunology & Rheumatology

πŸ‡ΊπŸ‡Έ

Baltimore, Maryland, United States

Cook County Hosp.

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

Univ. of Puerto Rico Ped. HIV/AIDS Research Program CRS

πŸ‡΅πŸ‡·

San Juan, Puerto Rico

Tulane/LSU Maternal/Child CRS

πŸ‡ΊπŸ‡Έ

New Orleans, Louisiana, United States

Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab.

πŸ‡ΊπŸ‡Έ

Oakland, California, United States

UMDNJ - Robert Wood Johnson

πŸ‡ΊπŸ‡Έ

New Brunswick, New Jersey, United States

Univ. of Illinois College of Medicine at Chicago, Dept. of Peds.

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

Schneider Children's Hosp., Div. of Infectious Diseases

πŸ‡ΊπŸ‡Έ

New Hyde Park, New York, United States

Baystate Health, Baystate Med. Ctr.

πŸ‡ΊπŸ‡Έ

Springfield, Massachusetts, United States

San Juan City Hosp. PR NICHD CRS

πŸ‡΅πŸ‡·

San Juan, Puerto Rico

Univ. of Rochester ACTG CRS

πŸ‡ΊπŸ‡Έ

Rochester, New York, United States

WNE Maternal Pediatric Adolescent AIDS CRS

πŸ‡ΊπŸ‡Έ

Worcester, Massachusetts, United States

SUNY Downstate Med. Ctr., Children's Hosp. at Downstate NICHD CRS

πŸ‡ΊπŸ‡Έ

Brooklyn, New York, United States

Columbia IMPAACT CRS

πŸ‡ΊπŸ‡Έ

New York, New York, United States

Univ. Hosp. RamΓ³n Ruiz Arnau, Dept. of Peds.

πŸ‡΅πŸ‡·

Bayamon, Puerto Rico

Harlem Hosp. Ctr. NY NICHD CRS

πŸ‡ΊπŸ‡Έ

New York, New York, United States

Univ. of Miami Ped. Perinatal HIV/AIDS CRS

πŸ‡ΊπŸ‡Έ

Miami, Florida, United States

UCSD Maternal, Child, and Adolescent HIV CRS

πŸ‡ΊπŸ‡Έ

San Diego, California, United States

UCSF Pediatric AIDS CRS

πŸ‡ΊπŸ‡Έ

San Francisco, California, United States

HMS - Children's Hosp. Boston, Div. of Infectious Diseases

πŸ‡ΊπŸ‡Έ

Boston, Massachusetts, United States

Texas Children's Hosp. CRS

πŸ‡ΊπŸ‡Έ

Houston, Texas, United States

BMC, Div. of Ped Infectious Diseases

πŸ‡ΊπŸ‡Έ

Boston, Massachusetts, United States

DUMC Ped. CRS

πŸ‡ΊπŸ‡Έ

Durham, North Carolina, United States

North Shore-Long Island Jewish Health System, Dept. of Peds.

πŸ‡ΊπŸ‡Έ

Great Neck, New York, United States

Bronx-Lebanon Hosp. IMPAACT CRS

πŸ‡ΊπŸ‡Έ

Bronx, New York, United States

Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU

πŸ‡ΊπŸ‡Έ

New Orleans, Louisiana, United States

Children's National Med. Ctr., ACTU

πŸ‡ΊπŸ‡Έ

Washington, District of Columbia, United States

NYU Med. Ctr., Dept. of Medicine

πŸ‡ΊπŸ‡Έ

New York, New York, United States

Metropolitan Hosp. NICHD CRS

πŸ‡ΊπŸ‡Έ

New York, New York, United States

UNC at Chapel Hill School of Medicine - Dept. of Peds., Div. of Immunology & Infectious Diseases

πŸ‡ΊπŸ‡Έ

Chapel Hill, North Carolina, United States

Β© Copyright 2025. All Rights Reserved by MedPath